Doctors from a private health facility in West Bengal have successfully treated a seven- year-old boy suffering from thalassaemia using an advanced Haplo Cord transplant process.
The patient was initially found to be having gait disturbance (an unusual change in the way a person walks). He was then diagnosed to have primary CNS lymphoma, a rare, aggressive type of non-Hodgkin lymphoma where cancer cells form in the brain, spinal cord, cerebrospinal fluid, or eyes. “Using the Haplo-cord technology for the child and the CAR T-cell therapy for the aged patient, the expert team of doctors attending them have been able to turn their lives around for the better. Narayana Health has always been at the forefront in breaking new grounds in medical science, and these two cases clearly reflect that,” Dr. Prasanta Chowdhury, Laboratory Director, Cord Life Sciences India Pvt. “The core dilemma centres on choosing between private storage for family use and public donation for general use, weighed against high costs and low statistical odds of personal use. In these two cases, we have successfully addressed every single concern with absolute compassion and clarity,” Dr.
In another feat, the team treated a 62-year-old male patient from Myanmar with brain cancer after a successful CAR T-cell therapy (an advanced type of immunotherapy).
Chakrabartty said. Limited, said that cord blood banking is a complex issue involving medical, financial, ethical, and scientific debates. Chowdhury said.
After receiving four cycles of high-dose chemotherapy yielding unsatisfactory results, the doctors decided to have him undergo CAR T-cell therapy. He underwent lymphocyte collection, bridging with radiation and other medications, before receiving a dual CAR targeting CD19 and CD22 on the cancer cells.
